BOSTON SCIENTIFIC CORPORATION
Clinical trial NCT06493903 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. primary completion date: 2026-06-30 → 2026-05-25 3. enrollment: 40 → 39 participants 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT06493903 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. primary completion date: 2026-06-30 → 2026-05-25 3. enrollment: 40 → 39 participants 4. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (67%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical